HSITF

Hadasit Bio Holdings Ltd.

USOTC

Add Alert

HSITF

Hadasit Bio Holdings Ltd.

USOTC

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

goodolboy

01/26/12 8:19 AM

Post #10

Re: #5: @Entangled Proton - Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly

"The Company was established for the purpose of promoting and commercializing the intellectual property and R&D capabilities generated by Hadassah."

So, it is established to pump stuff it doesn't own, making it a publicly traded paid promoter. Interesting.

goodolboy

01/26/12 8:09 AM

Post #9

Re: #3: @Entangled Proton - Not quite sure how this is going to

That seems odd to say the least. Trade other company's stock to raise money for their own company? First, how did they acquire the stock to begin with, and is there a balance sheet to view assets/holdings? And, where did they get the cash to purchase those shares, or what agreements were in place for a stock exchange?

Very strange indeed.

Entangled Proton Free

01/25/12 1:31 PM

Post #8

Re: #7: @Pythia - Do you have any thoughts about HSITF?

I found a contact number for the U.S. When get the time I'm going to use it. I have some very basic questions like why does 1 stock end with a "Y" and one with a "S".

Why is only one used in the PR's ? ect.

Pythia

01/25/12 6:57 AM

Post #7

Re: #1: @hurtszz - Nice company.

Do you have any thoughts about HSITF?

Entangled Proton Free

01/23/12 11:28 PM

Post #6

Shares Outstanding 87,523,450 a/o Jul 14, 2011

Entangled Proton Free

01/23/12 11:26 PM

Post #5

Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

http://ih.advfn.com/p.php?pid=nmona&article=50851106&symbol=HADSY

Entangled Proton Free

01/23/12 11:21 PM

Post #4

Business Description Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) in order to allow public participation in the highly promising field of biotechnology. It serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").

Entangled Proton Free

01/23/12 11:16 PM

Post #3

Not quite sure how this is going to work, but Hadasit will be using several US and foriegn stocks to raise money for research.

Pythia

03/07/11 10:38 AM

Post #2

Re: #1: @hurtszz - Nice company.

Well to post new finds on A PENNY FLIPPER

http://investorshub.advfn.com/boards/board.aspx?board_id=20062

hurtszz

03/07/11 8:29 AM

Post #1

Nice company.

Hadasit Bio Holdings Ltd. (HSITF)

Followers	1	Posters	4
Posts (Today)	0	Posts (Total)	10
Created	03/07/11	Type	Free
Moderators

Investing in Hadassah Based Biotech Companies

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE: HDST) in order to allow public participation in the promising field of biotechnology. It serves as a precedent in biotechnology financing - for the first time, public investment is allowed to participate in companies based on IP generated by Israel's foremost medical research center - the Hadassah University Hospital ("Hadassah"), which is responsible for the majority of Israel's hospital-based translational research.

The HBL traded stock, as a unique investment vehicle, provides investment exposure to a select portfolio of 6 biotech companies - all based on inventions developed and owned by Hadassah. The companies operate in the fields of Oncology (Rx and Dx), Regenerative Medicine and Inflammatory Disease.

HBL focuses on funding the preparation for and execution of Phase I and preparation for Phase II by the portfolio companies. Preparations include pre-clinical trials, manufacturing, regulatory and business development tasks.

HBL utilizes a competitive advantage symbolized as triple " I " : I nnovation, I nfrastructure & I nvestment.

Business Description
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) in order to allow public participation in the highly promising field of biotechnology. Now on OTC HSITF and OTC HADSY.
It serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israel's foremost medical research center - Hadassah University Hospital ("HU").